MGH-led study shows light therapy is safe, modulates brain repair, and may benefit patients with moderate traumatic brain injury.
Tags: harvard-medical-school health-medicine hms massachusetts-general-hospital mgh benjamin-vakoc light-therapy rajiv-gupta
Researchers have built two machine learning models that gauge biological age and predict remaining lifespan in mice.
Tags: science-technology machine-learning harvard-medical-school blavatnik-institute aging david-sinclair alice-kane michael-schultz
A Harvard Medical School student from Tanzania is working to help other international students navigate the process of getting into a U.S. medical school.
Tags: harvard-medical-school health-medicine alvin-powell application azan-virji f-1-doctors international-student medical-student zach-zhao
Harvard University and AbbVie have announced a $30 million collaborative research alliance to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever.
Tags: covid-19 harvard-medical-school health-medicine coronaviruses abbvie hemorrhagic-fever
Students from as far away as Africa and Asia are benefiting from a COVID-prompted shift online of an HMS program that gives high schoolers a taste of life in the exam room.
Tags: covid-19 harvard-medical-school health-medicine alvin-powell medical-education julie-joyal medscience nancy-oriol remote-learning secondary-education
The anger you’re seeing in the nation and your neighborhood — call it pandemic rage — is not in your imagination, according to a McLean hospital psychologist, who explains where it comes from and how to fight it.
Tags: mental-health covid-19 coronavirus pandemic harvard-medical-school health-medicine alvin-powell mclean-hospital david-h-rosmarin anger domestic-violence violence
Shifting the U.S.'s COVID-19 testing strategy to emphasize inexpensive, daily tests would break national transmission chains within weeks, an infectious disease testing expert said.
Tags: covid-19 coronavirus test harvard-medical-school health-medicine brigham-and-womens-hospital alvin-powell harvard-th-chan-school-of-public-health michael-mina center-for-communicable-disease-dynamics paper-strip-test
A new drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities
Tags: harvard-medical-school health-medicine partners-in-health mdr-tb bedaquiline delamanid endtb epicentre institute-of-tropical-medicine-in-antwerp interactive-research-development medecins-sans-frontieres multidrug-resistant-tb
Page 1 of 9